Jean-Charles Schwartz, Ph.D
Affiliations: |
Google:
"Jean-Charles Schwartz"Mean distance: 16.65 (cluster 11)
Children
Sign in to add traineeJean Costentin | grad student | ||
Elisabeth Traiffort | grad student | ||
Bruno Giros | grad student | 1983-1987 | INSERM, Paris |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Rusjan PM, Sabioni P, Di Ciano P, et al. (2020) Exploring Occupancy of the Histamine H3 Receptor by Pitolisant in Humans Using Positron Emission Tomography. British Journal of Pharmacology |
Lecendreux M, Plazzi G, Franco P, et al. (2019) Pharmacokinetics of pitolisant in children and adolescents with narcolepsy. Sleep Medicine. 66: 220-226 |
Setnik B, McDonnell M, Mills C, et al. (2019) Evaluation of the abuse potential of pitolisant, a selective H3-receptor antagonist/inverse agonist, for the treatment of adult patients with narcolepsy with or without cataplexy. Sleep |
Dauvilliers Y, Arnulf I, Szakacs Z, et al. (2019) Long-term use of pitolisant to treat patients with narcolepsy: Harmony III Study. Sleep |
Thorpy M, Schwartz J, Lecomte J, et al. (2018) 0624 Anticataplectic Efficacy of Pitolisant, the First Potent and Highly Selective Histamine H3-Receptor Antagonist/Inverse Agonist Sleep. 41 |
Szakacs Z, Dauvilliers Y, Mikhaylov V, et al. (2017) Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial. The Lancet. Neurology |
Levoin N, Labeeuw O, Billot X, et al. (2016) Discovery of nanomolar ligands with novel scaffolds for the histamine H4 receptor by virtual screening. European Journal of Medicinal Chemistry. 125: 565-572 |
Labeeuw O, Levoin N, Billot X, et al. (2016) Synthesis and evaluation of a 2-benzothiazolylphenylmethyl ether class of histamine H4 receptor antagonists. Bioorganic & Medicinal Chemistry Letters |
Schwartz JC, Lecomte JM. (2016) Clinical trials with H3-receptor inverse agonists: what they tell us about the role of histamine in the human brain. Neuropharmacology |
Capet M, Calmels T, Levoin N, et al. (2015) Improving selectivity of dopamine D3 receptor ligands. Bioorganic & Medicinal Chemistry Letters |